Trial intelligence / Profile preview

NSABP B-27: Preoperative AC vs AC + Docetaxel

NCT00002707Phase 3Completed

Sponsor
NSABP Foundation
Start
Dec 1995
Primary completion
Jun 2002
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of docetaxel in breast cancer, sponsored by NSABP Foundation. Started Dec 1995; status: completed.

02

Drugs

docetaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00002707.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00002707.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call